Month: <span>July 2023</span>

Home / 2023 / July
High intensity interval training combats fatty liver disease, study shows
Post

High intensity interval training combats fatty liver disease, study shows

by Flinders University Credit: Journal of Clinical and Translational Hepatology (2023). DOI: 10.14218/JCTH.2022.00091S Flinders University and University of Queensland research has found many people with fatty liver disease are unaware that high intensity interval training improves heart function and liver health. Dr. Shelley Keating from UQ’s School of Human Movement and Nutrition Sciences said fatty liver disease affects about 25%...

New study shows common blood pressure meds underused for migraine
Post

New study shows common blood pressure meds underused for migraine

by George Institute for Global Health Credit: Pixabay/CC0 Public Domain The first known large-scale review of international studies on the positive effect of blood pressure (BP) medicines across all classes in preventing migraine shows these common drugs could be used much more widely, at low cost, than is the case with current practice, according to a new...

Post

Long-Term Beta-Blocker Use May Not Benefit Certain Patients, Studies Find

By Cyra-Lea Drummond, BSN, RN Published on June 23, 2023 Fact checked by Nick Blackmer Key Takeaways Beta-blockers are a tried-and-true class of medications prescribed to patients who have experienced a heart attack or have heart failure. New research shows that long-term beta-blocker use may not improve outcomes in certain patients, particularly those whose heart function is only...

Researchers outline how AI chatbots could be approved as medical devices
Post

Researchers outline how AI chatbots could be approved as medical devices

by Dresden University of Technology Credit: Pixabay/CC0 Public Domain LLM-based generative chat tools, such as ChatGPT or Google’s MedPaLM have great medical potential, but there are inherent risks associated with their unregulated use in health care. A new Nature Medicine paper by Prof. Stephen Gilbert and colleagues addresses one of the most pressing international issues of our time:...

Produce prescription programs for patients with diabetes could save billions in health care costs, study shows
Post

Produce prescription programs for patients with diabetes could save billions in health care costs, study shows

by Joseph Caputo, Tufts University Credit: Arina P Habich / Shutterstock An apple a day not only keeps the doctor away, it also could save the United States at least $40 billion in medical bills, report Friedman School of Nutrition Science and Policy researchers in a new study published June 30 in the Journal of the American Heart Association....

New study reveals breakthrough ‘brain fitness program’ for patients with ADHD, concussion, memory loss
Post

New study reveals breakthrough ‘brain fitness program’ for patients with ADHD, concussion, memory loss

by IOS Press Patients with ADHD, PCS, and memory loss often suffer from several other symptoms and comorbidities that impact their cognitive functions. Credit: Journal of Alzheimer’s Disease Reports (2023). DOI: 10.3233/ADR-220091 Neurologist Dr. Majid Fotuhi, MD, Ph.D. has developed a multi-disciplinary program for patients with Attention Deficit Hyperactive Disorder (ADHD), post-concussion syndrome (PCS), or memory loss. His...

Researchers synthesize chimeric peptide that elicits antitumor activity for cancer immunotherapy
Post

Researchers synthesize chimeric peptide that elicits antitumor activity for cancer immunotherapy

by Science China Press The peptide Pal-DMPOP consists a peptide inhibitor of CD47/SIRPα, a D-peptide inhibitor of PD-1/PD-L1, and a palmitic acid tail conjugated at its N-terminal through a PEG4 linker. This design made this peptide resistant to serum proteolysis and accumulated in the tumor tissues. It can block CD47/SIRPα and PD-1/PD-L1 to enhance the phagocytosis...

Researchers identify unique cell receptor, potential for new therapies
Post

Researchers identify unique cell receptor, potential for new therapies

by CU Anschutz Medical Campus Credit: Unsplash/CC0 Public Domain Researchers from the University of Colorado Anschutz Medical Campus have identified a potential new immune checkpoint receptor that could lead to treatments for diseases such as lung and bowel cancer and autoimmune conditions including IBD. The study, published today in Science Immunology, examines a family of 13 receptors, or...

Post

Challenges and Advances in Brain-Computer Interfaces

Following the FDA approval for human clinical trials for brain tech startups, Anna Wexler of the Perelman School of Medicine discusses advances in brain-computer interfaces and looming ethical concerns. In a significant step forward in neurotechnology, companies that make implantable brain-computer interfacing (BCI) devices, such as Neuralink, have received approval from the U.S. Food and Drug Administration (FDA) to...

Multiple sclerosis: Myelin may be detrimental to nerve fibres
Post

Multiple sclerosis: Myelin may be detrimental to nerve fibres

UNIVERSITÄT LEIPZIG IMAGE: THE IMAGE SERIES SHOWS CROSS-SECTIONAL ELECTRON MICROGRAPHS OF INDIVIDUAL NERVE FIBERS IN MS BRAIN BIOPSIES. AXONS SHEATHED WITH MYELIN (BLACK RINGS) CAN BE SEEN, SHOWING INCREASINGLY SEVERE DAMAGE FROM 1 TO 8. THE SPECTRUM RANGES FROM ACCUMULATION OF INDIVIDUAL CELLULAR COMPONENTS IN OTHERWISE STILL BRIGHT, INTACT AXONS (1) TO ADVANCED DEGENERATION IN...